Nothing Special   »   [go: up one dir, main page]

HK1098467A1 - Processes for preparing anhydrous and hydrate forms of antihstaminic piperidine derivatives, polymorphs and pseudormophs thereof - Google Patents

Processes for preparing anhydrous and hydrate forms of antihstaminic piperidine derivatives, polymorphs and pseudormophs thereof

Info

Publication number
HK1098467A1
HK1098467A1 HK07104744.4A HK07104744A HK1098467A1 HK 1098467 A1 HK1098467 A1 HK 1098467A1 HK 07104744 A HK07104744 A HK 07104744A HK 1098467 A1 HK1098467 A1 HK 1098467A1
Authority
HK
Hong Kong
Prior art keywords
polymorphs
processes
pseudormophs
antihstaminic
piperidine derivatives
Prior art date
Application number
HK07104744.4A
Other languages
English (en)
Inventor
Daniel R Henton
Frederick J Mccarty
Susan I Tripp
Jill E Dewitt
Original Assignee
Aventisub Ii Inc
Ii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26937420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1098467(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventisub Ii Inc, Ii filed Critical Aventisub Ii Inc
Publication of HK1098467A1 publication Critical patent/HK1098467A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
HK07104744.4A 1994-05-18 2007-05-04 Processes for preparing anhydrous and hydrate forms of antihstaminic piperidine derivatives, polymorphs and pseudormophs thereof HK1098467A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24573194A 1994-05-18 1994-05-18
US41716195A 1995-04-11 1995-04-11

Publications (1)

Publication Number Publication Date
HK1098467A1 true HK1098467A1 (en) 2007-07-20

Family

ID=26937420

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07104744.4A HK1098467A1 (en) 1994-05-18 2007-05-04 Processes for preparing anhydrous and hydrate forms of antihstaminic piperidine derivatives, polymorphs and pseudormophs thereof
HK10101357.3A HK1137742A1 (en) 1994-05-18 2010-02-05 Processes for preparing anhydrous and hydrate forms of antihstaminic piperidine derivatives, polymorphs and pseudormophs thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK10101357.3A HK1137742A1 (en) 1994-05-18 2010-02-05 Processes for preparing anhydrous and hydrate forms of antihstaminic piperidine derivatives, polymorphs and pseudormophs thereof

Country Status (18)

Country Link
US (12) US20010012896A1 (xx)
EP (3) EP1178041A1 (xx)
JP (7) JPH10500134A (xx)
CN (3) CN1907967B (xx)
AT (1) ATE220667T1 (xx)
AU (1) AU693892B2 (xx)
CA (3) CA2189007C (xx)
DE (1) DE69527429T2 (xx)
DK (1) DK0766668T3 (xx)
ES (1) ES2176329T3 (xx)
FI (1) FI964565A0 (xx)
HK (2) HK1098467A1 (xx)
HU (1) HU227676B1 (xx)
IL (3) IL134917A (xx)
MX (1) MX9605613A (xx)
NO (1) NO315319B1 (xx)
PT (1) PT766668E (xx)
WO (1) WO1995031437A1 (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9400555D0 (en) * 1994-01-13 1994-03-09 Short Brothers Plc Boundery layer control in aerodynamic low drag structures
MX9605613A (es) 1994-05-18 1998-05-31 Hoechst Marion Roussel Inc Procedimiento para preparar formas anhidras e hidratadas de derivados de piperidina antihistaminica, polimorfos y pseudomorfos de los mismos.
DE69624559T2 (de) * 1995-02-28 2003-07-10 Aventis Pharmaceuticals Inc., Bridgewater Arzneizubereitungen für piperidinalkanolderivate
RU2207879C2 (ru) * 1997-08-26 2003-07-10 Авентис Фармасьютикалз, Инк. Фармацевтическая композиция для объединения пиперидиноалканола с противоотечным агентом
IN191492B (xx) * 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
US6613906B1 (en) * 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
CH695216A5 (de) 2001-02-23 2006-01-31 Cilag Ag Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes.
IL158334A0 (en) * 2001-04-09 2004-05-12 Teva Pharma Polymorphs of fexofenadine hydrochloride
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
EE200400010A (et) 2001-06-18 2004-02-16 Dr. Reddy's Laboratories Ltd. 4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid
US7700779B2 (en) 2001-06-18 2010-04-20 Dr. Reddy's Laboratories Limited Crystalline forms of fexofenadine and its hydrochloride
EP1414453B1 (en) * 2001-07-31 2008-03-19 Texcontor Etablissement Fexofenadine hydrochloride polymorph
US20030158227A1 (en) * 2001-11-08 2003-08-21 Barnaba Krochmal Polymorphs of fexofenadine base
DE03757471T1 (de) * 2002-06-10 2005-09-01 Teva Pharmaceutical Industries Ltd. Polymorphe form xvi von fexofenadin-hydrochlorid
JP3910907B2 (ja) * 2002-10-29 2007-04-25 新光電気工業株式会社 キャパシタ素子及びこの製造方法、半導体装置用基板、並びに半導体装置
US20050054616A1 (en) * 2003-07-03 2005-03-10 Judith Aronhime Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
GB0319935D0 (en) * 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
MXPA06012281A (es) * 2004-04-26 2007-07-18 Teva Pharma Formas cristalinas de clorhidrato de fexofenadina y procesos para su preparacion.
ITMI20041143A1 (it) * 2004-06-08 2004-09-08 Dipharma Spa Polimorfi di fexofenadina e procedimento per la loro preparazione
EP1616861A3 (en) * 2004-06-15 2006-02-08 Dipharma S.p.A. A process for the preparation of keto compounds
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
JP2008514641A (ja) * 2004-09-28 2008-05-08 テバ ファーマシューティカル インダストリーズ リミティド 結晶形フェキソフェナジン、およびその調製方法
DOP2006000274A (es) * 2005-12-14 2007-10-15 Sanofi Aventis Us Llc Formulación de suspensión de fexofenadina
KR20090037930A (ko) * 2006-07-11 2009-04-16 뮤추얼 파마슈티컬 컴퍼니 아이엔씨. 조절 방출 제형
US20090076080A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched fexofenadine
EP2105134A1 (en) 2008-03-24 2009-09-30 Ranbaxy Laboratories Limited Stable amorphous fexofenadine hydrochloride
US20100183717A1 (en) * 2009-01-16 2010-07-22 Kristin Arnold Controlled-release formulations
KR20120115492A (ko) 2009-11-06 2012-10-18 바스프 에스이 ４―히드록시 벤조산 및 선택된 살충제의 결정질 복합체
IT1400965B1 (it) * 2010-06-15 2013-07-05 Dipharma Francis Srl Polimorfi di fexofenadina
US9216955B2 (en) 2010-06-15 2015-12-22 Chemelectiva S.R.L. Polymorphic form of Fexofenadine hydrochloride, intermediates and process for its preparation
US9420872B2 (en) * 2010-08-23 2016-08-23 Jason Bird Apparatus and system for holding game-calling devices
JP2012087100A (ja) * 2010-10-21 2012-05-10 Sumitomo Chemical Co Ltd 形態ｉのフェキソフェナジン一塩酸塩の製造方法
CN104072402B (zh) * 2014-07-16 2016-08-17 昆山龙灯瑞迪制药有限公司 一种新结晶形式的盐酸非索非那定化合物及其制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US631375A (en) * 1899-04-12 1899-08-22 Ephraim Musselman Face-protector.
US3448152A (en) * 1966-11-03 1969-06-03 Jefferson Chem Co Inc Amine recovery
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3965257A (en) * 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
BE794598A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
JPH02213431A (ja) * 1989-02-13 1990-08-24 Kobe Steel Ltd ＳｉＣウィスカ強化Ａｌ合金複合材料
DE4034218A1 (de) 1990-10-27 1992-04-30 Merck Patent Gmbh Verfahren zur herstellung von carebastin
TW198008B (xx) * 1991-04-08 1993-01-11 Green Cross Corp
US5631375A (en) * 1992-04-10 1997-05-20 Merrell Pharmaceuticals, Inc. Process for piperidine derivatives
DE69332117T2 (de) * 1992-04-10 2003-01-30 Merrell Pharmaceuticals Inc., Cincinnati 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung
DE69320952T2 (de) * 1992-05-11 1999-05-27 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Verwendung von terfenadin-derivaten als antihistaminika in leberkranken patienten
KR950702420A (ko) 1992-08-03 1995-07-29 데이비드 사무소 웰 알레르기 질환 치료를 위한 테르페나딘 대사물과 그것의 광학 순수 이성체(terfenadine metabolites and their optically pure isomers for treating allergic disorders)
US5315016A (en) 1992-10-13 1994-05-24 Nycomed Dak A/S Process for preparing pure podophyllotoxin
EP1026147B1 (en) * 1993-06-24 2003-11-19 Albany Molecular Research, Inc. Compounds useful as intermediates in the production of piperidine derivatives
CA2181089C (en) 1993-06-24 2000-05-23 Thomas E. D'ambra Piperidine derivatives and process for their production
US6147216A (en) 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
NZ267830A (en) 1993-06-25 1998-05-27 Merrell Pharma Inc Preparation of 4-diphenylmethyl or 4-diphenylmethoxy piperidine derivatives and intermediates therefor
MX9605613A (es) 1994-05-18 1998-05-31 Hoechst Marion Roussel Inc Procedimiento para preparar formas anhidras e hidratadas de derivados de piperidina antihistaminica, polimorfos y pseudomorfos de los mismos.
US5576610A (en) * 1994-07-05 1996-11-19 Motorola, Inc. Method and apparatus for determining battery characteristics
IL134771A (en) 1995-02-28 2002-02-10 Aventis Pharma Inc Pharmaceutical compositions of piperidinoalkanol compounds in solid unit dosage form
DE69624559T2 (de) * 1995-02-28 2003-07-10 Aventis Pharmaceuticals Inc., Bridgewater Arzneizubereitungen für piperidinalkanolderivate
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
RU2207879C2 (ru) * 1997-08-26 2003-07-10 Авентис Фармасьютикалз, Инк. Фармацевтическая композиция для объединения пиперидиноалканола с противоотечным агентом
US6214427B1 (en) * 1998-08-28 2001-04-10 General Electric Company Method of making an electronic device having a single crystal substrate formed by solid state crystal conversion
US6613906B1 (en) * 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
US20020177680A1 (en) * 2000-08-23 2002-11-28 Hubbell Jeffrey A. Novel polymer compounds
US6475942B1 (en) * 2000-09-05 2002-11-05 General Electric Company Conversion of polycrystalline alumina to single crystal sapphire using molybdenum doping
IL158334A0 (en) * 2001-04-09 2004-05-12 Teva Pharma Polymorphs of fexofenadine hydrochloride
US7700779B2 (en) * 2001-06-18 2010-04-20 Dr. Reddy's Laboratories Limited Crystalline forms of fexofenadine and its hydrochloride
US20090211514A1 (en) * 2008-02-26 2009-08-27 Lehigh University Single crystal conversion process

Also Published As

Publication number Publication date
CA2585705C (en) 2012-04-17
US20030045721A1 (en) 2003-03-06
EP2354125A1 (en) 2011-08-10
NO315319B1 (no) 2003-08-18
CN1623985A (zh) 2005-06-08
IL113747A (en) 2001-05-20
ES2176329T3 (es) 2002-12-01
US20010012896A1 (en) 2001-08-09
EP0766668B1 (en) 2002-07-17
CA2189007C (en) 2004-03-02
MX9605613A (es) 1998-05-31
IL134917A (en) 2001-07-24
HU9603167D0 (en) 1997-01-28
US20020193603A1 (en) 2002-12-19
JP2010120969A (ja) 2010-06-03
HU227676B1 (en) 2011-11-28
DK0766668T3 (da) 2002-10-28
US20040014976A1 (en) 2004-01-22
IL113747A0 (en) 1995-08-31
US20020193600A1 (en) 2002-12-19
IL134917A0 (en) 2001-05-20
US20070021461A1 (en) 2007-01-25
US20080167469A1 (en) 2008-07-10
US20070021462A1 (en) 2007-01-25
US20010025106A1 (en) 2001-09-27
JP4503909B2 (ja) 2010-07-14
NO964859D0 (no) 1996-11-15
PT766668E (pt) 2002-11-29
CA2189007A1 (en) 1995-11-23
FI964565A (fi) 1996-11-14
EP0766668A1 (en) 1997-04-09
FI964565A0 (fi) 1996-11-14
US7135571B2 (en) 2006-11-14
CN1907967A (zh) 2007-02-07
CA2585705A1 (en) 1995-11-23
US7138524B2 (en) 2006-11-21
NO964859L (no) 1996-11-15
US20080167471A1 (en) 2008-07-10
CA2449419A1 (en) 1995-11-23
JP2002308849A (ja) 2002-10-23
ATE220667T1 (de) 2002-08-15
US7662835B2 (en) 2010-02-16
JP2002316978A (ja) 2002-10-31
CN1148849A (zh) 1997-04-30
US20020193601A1 (en) 2002-12-19
JP4503907B2 (ja) 2010-07-14
US20010014741A1 (en) 2001-08-16
CA2449419C (en) 2011-09-06
JPH10500134A (ja) 1998-01-06
AU693892B2 (en) 1998-07-09
HK1137742A1 (en) 2010-08-06
JP4503908B2 (ja) 2010-07-14
US7666881B2 (en) 2010-02-23
CN1907967B (zh) 2012-07-04
HUT76134A (en) 1997-06-30
JP2002255935A (ja) 2002-09-11
JP2002255936A (ja) 2002-09-11
WO1995031437A1 (en) 1995-11-23
JP2002308850A (ja) 2002-10-23
DE69527429D1 (de) 2002-08-22
EP1178041A1 (en) 2002-02-06
AU2426595A (en) 1995-12-05
DE69527429T2 (de) 2003-03-20

Similar Documents

Publication Publication Date Title
HK1098467A1 (en) Processes for preparing anhydrous and hydrate forms of antihstaminic piperidine derivatives, polymorphs and pseudormophs thereof
HU9301362D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
SG68556A1 (en) Novel method of producing 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
HU9302733D0 (en) Process for producing heterocyclic amine derivatives
HU9203110D0 (en) Method for producing amino-6-demethyl-desoxi-tetracycline derivatives substituted in locations 7 and 9 as well as pharmaceuitcal preparatives containing these compounds
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
DE69401817D1 (de) Verbesserungen zum herstellen von glasartigem silika
ATE188460T1 (de) Verfahren zum herstellen von derivaten des 4a,5,9,10,11,12,-hexahydro-6h-benzofuro(3a,3,2- ef)(2)benzazepins
TW362096B (en) Novel piperidine derivatives and the process for preparing the same
PL275056A1 (en) Method of obtaining derivatives of 4-aminopyridine
IL98256A0 (en) Preparation of substituted piperidines
HU906010D0 (en) New substituted alkyl-piperidine derivatives
HUT71511A (en) Piperazine derivatives for producing alkil-trazodone derivatives and process for producing them
SG76447A1 (en) Novel benzyl and benzhydryl alcohols
SG33391A1 (en) Polyalkylpiperidine compounds of the formula I
ZA953930B (en) Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives polymorphs and pseudomorphs
TH13553EX (th) กรรมวิธีที่ดีขึ้นสำหรับเตรียมเซฟาโลสพอรินส์

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20150427